2025-04-08 18:40:02
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Sun Pharma Advanced Research Company Ltd Q4FY22 net loss widens to Rs. 71.05 crores
Posted On : 2022-05-17 15:28:05( TIMEZONE : IST )
Sun Pharma Advanced Research Company Limited has reported Standalone financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 25.46 crores during the period ended March 31, 2022 as compared to Rs. 62.49 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. -71.05 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. -15.84 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. -2.69 for the period ended March 31, 2022 as compared to Rs. -0.60 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹ 25.46 crs | ₹62.49 crs |  -59.26% |
| Net Profit | ₹-71.05 crs | ₹-15.84 crs |  348.55% |
| EPS | ₹-2.69 | ₹-0.60 | 348.33% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs. 25.46 crores during the period ended March 31, 2022 as compared to Rs.28.39 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.-71.05 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.-56.72 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.-2.69 for the period ended March 31, 2022 as compared to Rs.-2.16 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹ 25.46 crs | ₹28.39 crs | -10.32% |
| Net Profit | ₹-71.05 crs | ₹-56.72 crs | 25.26% |
| EPS | ₹-2.69 | ₹-2.16 | 24.54% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.144.09 crores during the Financial Year ended March 31, 2022 as compared to Rs.258.37 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.-203.40 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.-151.14 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.-7.73 for the Financial Year ended March 31, 2022 as compared to Rs.-5.77 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹144.09 crs | ₹258.37 crs | -44.23% |
| Net Profit | ₹-203.40 crs | ₹-151.14 crs | 34.58% |
| EPS | ₹-7.73 | ₹-5.77 | 33.97% |
Shares of Sun Pharma Advanced Research Company Limited was last trading in BSE at Rs. 225.60 as compared to the previous close of Rs. 209.60. The total number of shares traded during the day was 52183 in over 2063 trades.
The stock hit an intraday high of Rs. 229.00 and intraday low of 210.40. The net turnover during the day was Rs. 11651018.00.
